At the Red Deer with the Founder of Xlear (pronounced Clear)

June 6, 2018

 

A memorable informal meeting from April 2007. Time to blog it. Having transferred from email to word to blog, this is McDawg’s longest post to date.

After downloading numerous maps about how to get from a railway station I had not been to before and walk about 1.5 miles to a travelodge that I had not been to before, I thought I was well equipped ahead of this meeting.

After getting off the train in no mans land, I only had one fellow passenger who got off the train with me to point me in the right direction. Getting from A to B on foot was obviously possible (they are both on land as far as I am aware) but would involve traversing motorways and the like. He pointed to a phone box and suggested I call a cab. Excellent idea but us Scottish are notoriously tight fisted. With no taxi numbers on me and none in the phone box (rare to even find a phone box these days) Hhmm.

After a few minutes, my taxi arrived from nowhere. £4 later – I was transported from A to B.

Not anticipating this 30 minute time warp into the future, I scoured the travelodge for Dr Lon Jones and his wife but the results came back negative. I went out for a smoke. 3 puffs in and a gentleman came round the corner. When I spoke with Lon on Tuesday, I told him that I had seen his picture on the web and as such, I would be able to recognise him. This gentleman certainly looked like him from a distance. As he came closer ……………. yep, that’s him. “Hi Lon” I said as he sailed by me. “Graham?” he said. “Your early” he said looking at his timepiece. I explained (pointing at map at the time) how I had just had a time warp experience in a mystery vehicle called a taxi (a little travelled in but handy vehicle used sparingly by Scotsmen unless blind drunk with no other option to get from B to A).

He left me to finish my cigarette but clearly was unaware that such an experience at a leisurely pace not uncommonly can take a few minutes. As I stubbed out the offending substance, he re-appeared at the door as I entered the Travelodge in no mans land.

He was quizzical about precisely where I had seen his photo. (Ed – from the Xlear website !!)


Dr Lon Jones and Jerry Bozeman

I said that I could not recall where I had seen it. Clearly, he and Mrs Jones had had a conversation vis a vis this issue whilst I had been puffing away outside. He said, “you probably wouldn’t have recognised my wife then (as I shook her hand) as she’s grown her hair.” Indeed this was a factually correct statement to make.

Chapter 1

We proceeded to move to a quiet table away from the burl of the current residents and visitors of the Red Deer Village, Innkeeper’s Lodge, Cumbernauld, Glasgow. Being situated (Ed – A80 actually) just 200m away from the busiest Motorway in Scotland, no deer were visible but they certainly would have been coated in red were they to roam around such a highway.

Mrs Jones was supping on the last drops of a pint of fine ale. After some brief opening pleasantries, Lon asked how I had become involved in CJD. I said that I thought he might ask that and had flung together the previous night some documentation that might be useful during our discussion. I responded with “what sort of music are you guys into?” and proceeded to ruffle through my rucksack for a CD that I thought would be a good closer but turned out to be a great ice-breaker. A copy of “Steck – The Best Bitz” (20 track compilation of work I recorded from 1985 – 2000). Took them both completely by surprise by this. Mrs Jones now known as Jerry mentioned that their hire car has a CD player but they have no CD’s. As such, whilst Lon’s musical taste in particular not in line with the content of the CD, at the very least, this will get listened to. They’re off to Iona the day after this discussion and after that, Eire and N Ireland.

Chapter 2

In contrast to previous face to face discussions with newish contacts, surprisingly, I took little notes – indeed, less than a page over the space of three hours intense conversation. Jerry I sensed was also a PhD. Indeed, she is a registered and practising psychotherapist. After revealing the nature of my day job, I jokingly suggested that maybe I could refer some of my clients to her. In part this was taken seriously until they both realised the irony of my remark. Both are clear thinkers.

Down to business and more ruffling of aforementioned rucksack or “rucky” as is referred to in this locale.

Now back home, the content of my rucky is much lighter and out of sync (content wise) than when it left these four walls this morning. I would add that I am pleased to still have four walls and a floor after my downstairs neighbour removed a large wall yesterday. Stewards’ enquiry is currently at stage two. Not as bad as initially suspected.

Dipping into sections 3 & 4 of rucky yielded the best documentation. In the meantime, “Pentosan Polysulphate by Linda Curreri” was eloquently passed over to Lon. This was my own personal copy as I was unable to locate the second copy that Linda sent to me which was originally destined for Ian Anderson from Jethro Tull who gets a mention in the foreword.

The “Timeline” of events document from 2000 to the current day was a great guider from time to time during the discussion. To answer Lon’s gambit, I briefly mentioned my brother and after a two year time lag, my band split up and it was maybe time (after 20 years in the semi-prof and amateur business) to try something else. I explained how I had been called a week after the band break up to consider being Vice-Chair of a (later to become Charity) CJD Support Group. I went onto explain that at the tender age of 32, to me, it seemed like an interesting but challenging role for me to consider, let alone accept. How right I was!!

Chapter 3

Lon intensely read Linda’s book and recalled that he had first heard from her (from memory) around 1999 – 2000. I remarked that I had not connected with Linda until 2003 but had remained in contact with her on a very regular basis right up to the current day. It became Xlear, sorry, clear that Lon had missed an opportunity to drop by and meet Linda face to face when he and Jerry were in New Zealand two years ago. They do however plan to return and most certainly will wish to meet this courageous and intensely interesting individual next time around. Not that it seemed to be required but the writer encouraged such an operchancity.

With Lon still engrossed in Linda’s book, I spoke at some length with Jerry about music and Church organs none the less. Personally, I had only played one about twice back in the Eighties when our, at the time Rev’d, was not in the building.

After a brief (but it ties in) relapse into the beginnings of my musical training at the piano and more importantly, keyboards etc etc, we went back to business and Jerry picked up again, her copy of today’s “The Independent” courtesy of the travelodge. Later on, I myself picked a free copy of this 70p ‘newspaper’, found little news but pages upon pages of advertisements. (These days, If I want news, I usually use the Internet.)

Chapter 4

My guests are both Vegetarians – I am not – omnivore. Having studied the menu, this was a vegetarian’s nightmare. Being polite (the cheeseburger option was most tempting), I went with the flow and three carrot/coriander/leek soups and crusty bread were swiftly delivered and quickly consumed. A second round could easily have been eaten up.

Unexpectedly, our (three hour) discussion transpired to be led namely by myself. It turned out that Lon was namely interested in anatomy related matters, but also very interested in issues namely such as preventative measures and how to rebalance internal human environments when faced with rogue bacterium and proteins.

I mentioned my contact with Dr Ellie Philips and how she had kindly sent me a shipload of Xylitol products and brought out some mints and gums. Lon quickly produced his own supply of Xylitol gum and an all round teeth cleansing moment took place. After all, in dental terms, this was one of the direct points of having this discussion. We practice what we “preach” type thing I suppose.

Lon knew a bit about ‘Prion disease’ but not much on the anatomy. The best way to respond was to describe the apparent misfolding of normal protein PrPc (of which little but some is known about) and the “misfolded” version until recently described as PrPsc. Now knee deep into scientific matters, Jerry walloped down a rather tasty looking Irish Coffee and went upstairs for a well earned rest judging from what I could gather.

With Lon now interested in “Prions” and the Nobel Prize Winner who coined a name for something that does not appear to actually exist (with certainty), he became more than interested on what we were trying to do to stop the relentless progression of the disease (PrPd) in humans specifically in Pentosan terms.

At this point, it was reasonable to re-dig my rucky and pull out further documentation. In the end, all “cards” were on the table (literally) and I told him to take away whatever he wanted. He did and thanked me for being so open.

Chapter 5 – The Book

My Xylitol contact list. This was and still is a working document, i.e., it is incomplete and subject to change. This was of immense interest to Lon. Lon (as I knew already) has a Patent on his Xlear Nasal Spray. Osmotically speaking, this is where everything made total and complete scientific sense. So, fighting bacterium is what mainly drives Lon. If I spin back to part of what he wrote to me if February, this now makes better sense.

“I am working on a book that deals with shifting our paradigm from the mechanical model to a complex one that honours the adaptations we and our evolutionary ancestors have made that helps us to deal more effectively with hostile agents in our environments. The billion dollars made by blocking such adaptations (fever, diarrhoea, rhinorrhea, to name just a few) is a large force that will not take this kindly”.

Around this time, Lon expanded upon his current book. This largely is complete pending a publisher that is sufficiently interested in making this widely available.

Currently dubbed “K C”, this book is about the Complex Adaptive System (previously dubbed CAS) When rogue bacterium enter their new “host”, they are extremely good at self replication and in certain terms millions of times over. Lon’s work deals with bringing internal environments back to their natural status and thus taming unwanted host particles. The rampant smart particles do not/never anticipate such a fight back and eventually go on to die. The system can therefore be restored back to normality not by fighting the bacterium, but by reinforcing the natural environment.

Does this work? It might do. Has this been tried? Yes. See here. Specifically, in relation to ear infection, a successful clinical trail (“n” of ~ 160 measured via similar “n” control) took place around 2005 but not accepted for publication. Since I am now aware that unpublished material can be less, equally and/or more interesting than published material, I look forward to viewing this section of the Author’s currently unpublished material. On the face of it, Xylitol as already very well documented in fighting off bacteria that causes dental decay is apparently effective when delivered intranasally.

Fully aware that Lon has patented this, this was not surprising. That said, in the commercial world that we live in, this was not surprising. Indeed, Lon mentioned a team in the US that cottoned on to “CAS” and intranasal Xylitol and carried out a clinical trial. Kind of handy for Lon when he found out and told them that he had the Patent.

Chapter 6

With the contents of my rucky pretty much now everywhere, but some still not on the table Lon looked at what was still in rucky. I told him to look through – no problem.

Around this time, we spoke about a number of issues but preventative measures came up several times. He mentioned a book that he and Jerry had just finished reading by a Dr Colin Campbell entitled “The China Study”. This I must check out.

My new friends seemed quite taken by their copy of handout “CJD Alliance Glasgow 2006” In particular; Lon was extremely interested in connecting with the Chair of that discussion, Dr Mark McClean. Moreover, Lon was I sense quite taken by Dr McClean’s summary from the Minutes of the discussion:-

“What have we achieved this afternoon?”

1. Three Medical Presentations. One on diagnostics, one on therapeutics and one on the problems inherent in tackling the different TSE strains. We asked today’s most important question – “what about systemic PrPd?”
2. The Legal Presentation – a vital branch in the past and present multidisciplinary approach to CJD/TSE. Mr Body’s success reflected his specialisation in the field – something our National Health Service should mirror.
3. Inevitable improvement of future research by our interested parties as they take away new knowledge acquired at this afternoon’s Discussion.
4. Further essential ‘networking’ between various interested parties – not to be underestimated.

Before closing this discussion, a number of points came to mind. Open Access in terms of medical research had been touched upon but I wanted to raise this again. Lon mentioned that he had received three requests for his first published Paper and zero for his second. We warmed superbly to the philosophy of Open Access via the Internet and asked how long I had been using the web. Six years. “Do you use Google to search for medical research?” Lon enquired. No, at the moment, PubMed but also now Open Access outlets and stressed the point that in Abstract form, it is impossible to fully evaluate a Paper. Having mentioned my recent conversation and contact with Peter Suber, Lon vigorously warmed to the OA philosophy and fully intends to make direct contact with him. Excellent news.

Having shared with Lon a copy of my Xylitol contact list, I sense he was a bit taken aback by this. Whilst he has a hard copy, I stressed that this was an e-document that contains many many active links. Copy now emailed to him.

Lon made mention of his Son Nathan and told me a bit about him. I asked if he had any other children. Thirteen. I thought he was being whimsical. No, he has fourteen kids via his first wife. Wow. For a period of around twenty odd years, he was certainly active. This man certainly has the largest family that I am personally aware of.

Chapter 7

As we closed up, I took stock. I had and indeed have a number of ‘action points’ that I will follow up. These were unexpected but much welcomed. Despite doing most of the talking, I had spent the afternoon with an extremely intelligent but somewhat reclusively mind mannered man. Whilst we may not meet again, we will certainly keep in touch – no question.

Would I require to conjure up another mystery taxi I was thinking? Thankfully no as Lon kindly offered to drive me back to the railway station in no mans land. As it happened, my main map came in rather handy after all and our direct route happened to be about twice as short at that of the one used by the mystery taxi driver !! This appears to be global phenomena. As such, the aforementioned comment about why Scotsmen only use such means of transportation sparingly. I rest my case.

As we arrived at my station, my twice an hour (I had no idea when) mystery train was there and just about to head off. A hasty goodbye and off I ran and JUST managed to board.

Goodbye Lon & Jerry

THE END

No comments:

Advertisements

“Open Access” at Bentham Science Publishers ?

January 2, 2018
0e1fe58

This caught my attention.

As did this.

Bentham1

So, having found an example of an “Open Access” (apparently CC-BY) paper at Bentham, as a reader, I have to comply with the following legalese when clicking on “Download”.
It gets worse.
When clicking on “Rights & Permisison” tab for this paper, more legalese….
Bentham2
Something fishy going on here.
Maybe something to do with a true source conflict.

And

PLEASE READ THESE END USER TERMS CAREFULLY

These end user terms (“Terms”) apply between you (“you”) and BENTHAM SCIENCE PUBLISHERS LIMITED of Executive Suite Y-2, PO Box 79127, Saif Zone, Saif, Sharjah, United Arab Emirates (“Bentham Science”) for the articles made available via the Website http://www.eurekaselect.com (each an “Article”).

These Terms shall at all times be read subject to applicable law. Bentham Science licenses Articles accessed by you via the Website to you on the terms set out in these Terms, and (if applicable) subject to any commercial terms otherwise applicable as between you and Bentham in respect of your use of or access to the Website, and by so accessing you agree to be bound by these Terms. Bentham Science or its licensors remain the owners of the Article (including any intellectual property rights in the same) at all times, and no right, title or interest in any Article is transferred to you by way of the Terms; you are simply granted a limited right to use the Article as per the terms set out in these Terms. If you do not agree to these Terms, you should immediately cease accessing Articles via the Website.

  1. GRANT AND SCOPE OF LICENSE

    1. Bentham Science licenses your use of the Articles as follows:
      1. Open Access Articles: if the Article is noted is being made available as Open Access, it is done so under the Creative Commons license CC-BY 4.0 (a “CC Article”). You are granted a non-exclusive, non-transferable license to use the Article under the terms of the Creative Commons license CC-BY 4.0, further details of which may be found here: https://creativecommons.org/licenses/by/4.0/legalcode ; Complete terms and condition are given below for your reference purpose;
      2. Trial Articles: if the Article is noted as being made available as a free trial (a “Trial Article”), you are granted a non-exclusive, non-transferable license to use the Promotional Article in accordance with these Terms and subject to the limited period of time agreed between the institution to which you belong and Bentham (usually three months), at the end of which you will no longer be entitled to use the Article;
      3. Promotional Articles: if the Article is noted as being made available at no cost (a “Promotional Article”), you are granted a non-exclusive, non-transferable license to use the Promotional Article in accordance with these Terms; and
      4. Payable Articles: if the Article is noted as being made available for purchase (a “Payable Article”), upon payment of the relevant fees in full you are granted a non-exclusive, non-transferable license to use the Payable Article in accordance with these Terms.
    2. If you require a license for a Trial Article, a Promotional Article or a Payable Article that differs from the terms noted herein (such as for use within a generally available library of content or for multiple users), please contact permission@benthamscience.org. (Please note that a CC Article cannot be licensed on any other terms.) If you have any queries about the scope of approved use of an Article, please contact Bentham Science.
    3. You acknowledge that all intellectual property rights in or to the Article, throughout the world, belong to Bentham Science or its licensors, and that you have no intellectual property rights in or to the Article other than the right to use the Article in accordance with the terms set out these Terms.
    4. Bentham Science hereby grants you, in accordance with these Terms, a non-exclusive, non-transferrable license to use the Article in the course of personal study or research (including research for commercial purposes in the context of a university or other research institution); such right to use shall not extend to any other commercial, business or resale purposes, except where otherwise specifically permitted by Bentham Science in writing.
  2. RESTRICTIONS

    1. Except as expressly set out in these Terms or as otherwise explicitly permitted by agreement with Bentham Science or by applicable law (and then only to the limited extent so permitted), you undertake to:
      1. refrain from copying the Article (except that you may make a single copy for back-up purposes, including by storing it on a storage device owned or controlled by you);
      2. refrain from sub-licensing or otherwise supplying or communicating the Article, in whole or in part, to the public or to any other third party, through any media or communications networks;
      3. refrain from translating, merging, adapting or modifying the Article, in whole or in part, or allowing it to be combined with, or become incorporated in, any other articles or written materials;
      4. include on the Article a suitable copyright notice on all entire and partial copies of the Article in any form.
  3. NO WARRANTY; LIMITATION OF LIABILITY

    1. The Article is provided “as is” without warranty of any kind, either express or implied or statutory, including, without limitation, implied warranties as to title, merchantability, fitness for a particular purpose, non-infringement, accuracy or currency.
    2. The entire risk as to your use of the Article is assumed by you. Neither Bentham Science nor its owners, directors, employees, contractors and/or authors can be held liable for any damages, including, without limitation, special, incidental and/or consequential damages arising (whether directly or indirectly) out of your use, or inability to use, the Article in any manner (even if used by you in accordance with the terms of the relevant license) or from any use or operation of any methods, processes, instructions, or ideas reflected in, or inspired by, the Article.
  4. TERMINATION

    1. Bentham Science may terminate these Terms immediately by written notice to you and without the need for a court order if you commit a material or persistent breach of these Terms (including without limitation exceeding the scope of the terms on which you are able to use the Article) which you fail to remedy (if remediable) within 14 days after the service of written notice requiring you to do so.
    2. Upon termination for any reason:
      1. all rights granted to you under these Terms will cease;
      2. you must cease all activities authorised by these Terms; and
      3. you must immediately delete or remove the Article from all equipment in your possession.
    3. Termination by Bentham Science shall be without prejudice to Bentham Science’s rights to claim damages or other remedies from you in respect of any infringement of intellectual property rights or other causes of action resulting from your use of the Article other than in accordance with these Terms. In addition, you agree to indemnify Bentham Science for any damages, fees or costs payable by Bentham Science to any third parties as a result of your infringing use of the Article.
  5. GOVERNING LAW AND JURISDICTION

    Any dispute or claim arising out of or in connection with these Terms will be governed by and construed in accordance with the laws of the United Arab Emirates as applied in the Emirate of Dubai. The courts of the Emirate of Dubai will have exclusive jurisdiction over any dispute arising out of or in connection with these Terms.

  6. COMMUNICATIONS BETWEEN THE PARTIES

    If you wish to contact Bentham Science, or if any condition in these Terms requires you to give Bentham Science notice in writing, you can send this to Bentham Science by email at mahmood@benthamscience.org. If Bentham Science has to contact you, including by giving notice in writing, it will do so at the email address you provide to Bentham Science when registering to access the Article.

By accessing the Articles, you agree to these Terms. If you do not agree to these Terms, you should immediately cease accessing Articles via the Website.

© Bentham Science Publishers Ltd – 2017

Copyright can be confusing. Please make it less confusing !

December 18, 2017

copyleftcopyright image CC logo

copyright 1

Just stumbled across a paper licensed under an Academic Free License (AFL) 3.0.

I don’t recall seeing such a license before. My gut reaction from the name suggested this might be similar to CC0/Public Domain.

The wording however is not as straightforward as one might think…

confused

Academic Free License (“AFL”) v. 3.0This Academic Free License (the “License”) applies to any original work of authorship (the “Original Work”) whose owner (the “Licensor”) has placed the following licensing notice adjacent to the copyright notice for the Original Work:

Licensed under the Academic Free License version 3.0

1) Grant of Copyright License. Licensor grants You a worldwide, royalty-free, non-exclusive, sublicensable license, for the duration of the copyright, to do the following:

a) to reproduce the Original Work in copies, either alone or as part of a collective work;

b) to translate, adapt, alter, transform, modify, or arrange the Original Work, thereby creating derivative works (“Derivative Works”) based upon the Original Work;

c) to distribute or communicate copies of the Original Work and Derivative Works to the public, under any license of your choice that does not contradict the terms and conditions, including Licensor’s reserved rights and remedies, in this Academic Free License;

d) to perform the Original Work publicly; and

e) to display the Original Work publicly.

2) Grant of Patent License. Licensor grants You a worldwide, royalty-free, non-exclusive, sublicensable license, under patent claims owned or controlled by the Licensor that are embodied in the Original Work as furnished by the Licensor, for the duration of the patents, to make, use, sell, offer for sale, have made, and import the Original Work and Derivative Works.

3) Grant of Source Code License. The term “Source Code” means the preferred form of the Original Work for making modifications to it and all available documentation describing how to modify the Original Work. Licensor agrees to provide a machine-readable copy of the Source Code of the Original Work along with each copy of the Original Work that Licensor distributes. Licensor reserves the right to satisfy this obligation by placing a machine-readable copy of the Source Code in an information repository reasonably calculated to permit inexpensive and convenient access by You for as long as Licensor continues to distribute the Original Work.

4) Exclusions From License Grant. Neither the names of Licensor, nor the names of any contributors to the Original Work, nor any of their trademarks or service marks, may be used to endorse or promote products derived from this Original Work without express prior permission of the Licensor. Except as expressly stated herein, nothing in this License grants any license to Licensor’s trademarks, copyrights, patents, trade secrets or any other intellectual property. No patent license is granted to make, use, sell, offer for sale, have made, or import embodiments of any patent claims other than the licensed claims defined in Section 2. No license is granted to the trademarks of Licensor even if such marks are included in the Original Work. Nothing in this License shall be interpreted to prohibit Licensor from licensing under terms different from this License any Original Work that Licensor otherwise would have a right to license.

5) External Deployment. The term “External Deployment” means the use, distribution, or communication of the Original Work or Derivative Works in any way such that the Original Work or Derivative Works may be used by anyone other than You, whether those works are distributed or communicated to those persons or made available as an application intended for use over a network. As an express condition for the grants of license hereunder, You must treat any External Deployment by You of the Original Work or a Derivative Work as a distribution under section 1(c).

6) Attribution Rights. You must retain, in the Source Code of any Derivative Works that You create, all copyright, patent, or trademark notices from the Source Code of the Original Work, as well as any notices of licensing and any descriptive text identified therein as an “Attribution Notice.” You must cause the Source Code for any Derivative Works that You create to carry a prominent Attribution Notice reasonably calculated to inform recipients that You have modified the Original Work.

7) Warranty of Provenance and Disclaimer of Warranty. Licensor warrants that the copyright in and to the Original Work and the patent rights granted herein by Licensor are owned by the Licensor or are sublicensed to You under the terms of this License with the permission of the contributor(s) of those copyrights and patent rights. Except as expressly stated in the immediately preceding sentence, the Original Work is provided under this License on an “AS IS” BASIS and WITHOUT WARRANTY, either express or implied, including, without limitation, the warranties of non-infringement, merchantability or fitness for a particular purpose. THE ENTIRE RISK AS TO THE QUALITY OF THE ORIGINAL WORK IS WITH YOU. This DISCLAIMER OF WARRANTY constitutes an essential part of this License. No license to the Original Work is granted by this License except under this disclaimer.

8) Limitation of Liability. Under no circumstances and under no legal theory, whether in tort (including negligence), contract, or otherwise, shall the Licensor be liable to anyone for any indirect, special, incidental, or consequential damages of any character arising as a result of this License or the use of the Original Work including, without limitation, damages for loss of goodwill, work stoppage, computer failure or malfunction, or any and all other commercial damages or losses. This limitation of liability shall not apply to the extent applicable law prohibits such limitation.

9) Acceptance and Termination. If, at any time, You expressly assented to this License, that assent indicates your clear and irrevocable acceptance of this License and all of its terms and conditions. If You distribute or communicate copies of the Original Work or a Derivative Work, You must make a reasonable effort under the circumstances to obtain the express assent of recipients to the terms of this License. This License conditions your rights to undertake the activities listed in Section 1, including your right to create Derivative Works based upon the Original Work, and doing so without honoring these terms and conditions is prohibited by copyright law and international treaty. Nothing in this License is intended to affect copyright exceptions and limitations (including “fair use” or “fair dealing”). This License shall terminate immediately and You may no longer exercise any of the rights granted to You by this License upon your failure to honor the conditions in Section 1(c).

10) Termination for Patent Action. This License shall terminate automatically and You may no longer exercise any of the rights granted to You by this License as of the date You commence an action, including a cross-claim or counterclaim, against Licensor or any licensee alleging that the Original Work infringes a patent. This termination provision shall not apply for an action alleging patent infringement by combinations of the Original Work with other software or hardware.

11) Jurisdiction, Venue and Governing Law. Any action or suit relating to this License may be brought only in the courts of a jurisdiction wherein the Licensor resides or in which Licensor conducts its primary business, and under the laws of that jurisdiction excluding its conflict-of-law provisions. The application of the United Nations Convention on Contracts for the International Sale of Goods is expressly excluded. Any use of the Original Work outside the scope of this License or after its termination shall be subject to the requirements and penalties of copyright or patent law in the appropriate jurisdiction. This section shall survive the termination of this License.

12) Attorneys’ Fees. In any action to enforce the terms of this License or seeking damages relating thereto, the prevailing party shall be entitled to recover its costs and expenses, including, without limitation, reasonable attorneys’ fees and costs incurred in connection with such action, including any appeal of such action. This section shall survive the termination of this License.

13) Miscellaneous. If any provision of this License is held to be unenforceable, such provision shall be reformed only to the extent necessary to make it enforceable.

14) Definition of “You” in This License. “You” throughout this License, whether in upper or lower case, means an individual or a legal entity exercising rights under, and complying with all of the terms of, this License. For legal entities, “You” includes any entity that controls, is controlled by, or is under common control with you. For purposes of this definition, “control” means (i) the power, direct or indirect, to cause the direction or management of such entity, whether by contract or otherwise, or (ii) ownership of fifty percent (50%) or more of the outstanding shares, or (iii) beneficial ownership of such entity.

15) Right to Use. You may use the Original Work in all ways not otherwise restricted or conditioned by this License or by law, and Licensor promises not to interfere with or be responsible for such uses by You.

16) Modification of This License. This License is Copyright © 2005 Lawrence Rosen. Permission is granted to copy, distribute, or communicate this License without modification. Nothing in this License permits You to modify this License as applied to the Original Work or to Derivative Works. However, You may modify the text of this License and copy, distribute or communicate your modified version (the “Modified License”) and apply it to other original works of authorship subject to the following conditions: (i) You may not indicate in any way that your Modified License is the “Academic Free License” or “AFL” and you may not use those names in the name of your Modified License; (ii) You must replace the notice specified in the first paragraph above with the notice “Licensed under ” or with a notice of your own that is not confusingly similar to the notice in this License; and (iii) You may not claim that your original works are open source software unless your Modified License has been approved by Open Source Initiative (OSI) and You comply with its license review and certification process.

Quite a lot of text right ?

copyright

After a quick search, the AFL license dates back to 2002 and was released in the same era as the launch of the Creative Commons ones.

The wording (human-readable summary) as below of the Creative Commons CC0/Public Domain one is much more easier to understand.

public domain

Chatting with the Guardian Science Podcast – a Pod Delusion Special

September 12, 2017

pod delusion extra

Originally posted here September 9, 2011. The audio file no longer works. Thankfully, I found a copy on my hard drive, hence this post.

Ahead of last week’s Science Online conference in London, Graham Steel and James O’Malley sat down with Alok Jha, Mo Costandi and James Meikle from the Guardian to discuss science reporting and related issues.

Topics tackled include churnalism, linking to papers, and the changes in the landscape of science journalism over the last couple of years.

03:09 – 13:27 Discussion about the background of the Guardian’s Science Weekly Podcast
13:28 – 17:44 How much science literacy can you assume in your audience when reporting on science?
17:55 – 32:07 Churnalism.What is it and how common is it in terms of Journalism and Blogging?
32:10 – 36:10 Including links to Science Manuscripts in online news articles
36:11 – 42:15 George Monbiot’s Guardian article “Academic publishers make Murdoch look like a socialist”
42:16 – 52:01 The change in the landscape/ecosystem of science blogging over the last 12 months or so
52:07 – 52:44 The use of social media during the recent riots in London and elsewhere
52:50 – 58:37 World’s first clinical trial of stem cells to treat strokes is set to move to its next phase

Talk on preprints at ReConEvent

August 28, 2017

At ReConEvent in June this year, we were very keen to attract a speaker to provide a talk for us on preprints. Of the three speakers we asked, all were keen to come (one from the USA, the others from the UK) but none of them were able to come on the day in question. Since this is a subject that I have been closely following for many years now, we decided a month before that I would deliver it myself. This event is now in it’s 5th year and I’ve never given a talk at it before so felt the time had come.

I chose the title as “Preprints: a journey though time(yes, this talk did contain a few Doctor Who gags) which I hope was self explanatory. I spent roughly 4 weeks (on and off) putting my slides together and rehearsed it several time in advance and timed it at 12 minutes. Twitter was a good venue to get ideas/feedback on the content.

preprint journey

We had a number of possible uncoference ideas (this was one of them) and it was delivered in the breakout room. As we had two cameramen this year, thankfully the talk was recorded and as matters stand, is the most viewed video from the event.

Preprints: a journey though time from Graham Steel

SLIDES

Last Slide – Further Reading

¨Preprint FAQ

¨The Rise of Preprints

¨The selfish scientist’s guide to preprint posting

¨Ahead of the curve: embracing preprints

¨The Role of Preprints in Journal Publishing

¨The Rise of Preprints in Physics, Mathematics, and Computer Sciences

¨The arXiv of the future will not look like the arXiv

//platform.twitter.com/widgets.js

Since this session had an allocated time of ~35 minutes, this meant there was time for a general discussion in the remaining time which was mostly preprint related.

 

“We’re Librarians”

July 16, 2017

RLC

When blogging, I tend to leave the title until last (as I did here). I chose this one as it reminded me of a title I used before but in a different setting – “We’re Scientists”

On July 15th 2017, Radical Librarians Collective (RLC) had a meet up here in Glasgow. These have been taking place annually around the UK since 2013, but this was the first one north of the border.

There is no central committee running RLC hierarchically. The Collective grew organically out of  conversations between like-minded library workers, and its membership continues to be fluid and evolving. You don’t have to be a library worker to be part of the Collective: RLC thrives on collaboration and open discussion so everyone is very welcome to contribute in whatever way and to whatever extent they are able.

The format of the event was an unconference setting, was free to attend and was held at the Glasgow Women’s Library in Bridgeton in the East End of Glasgow.

glasgow-womens-library-collective-architecture-scotland_dezeen_1568_2

This slideshow requires JavaScript.

Being a free to attend event, not all who signed up came along on the day, but most did, ~40 attendees. The format for the day was clear and informative. Being an unconference, a rough schedule was put in place in advance and several pitches were made.

The event began.

Bridgeton4

Having not been to an RLC event before, I was impressed at the level of detail that had been thought out in advance “to mitigate barriers to engagement within the group”. SOURCE

One thing that initially took me by surprise (but swiftly understood why) was that Chatham House Rule was in place for the meeting. One is aware of the rule but has only been to one event before (2010) where this applied.

The Cost of Open Access ?

In this instance however, tweeting was permitted providing that attendees did not associate things said to who said them. All complied with this. The # for the day was #radlib17 and here are all the related tweets.

The actual topics for the sessions unfolded.

After a welcome and introductions, the first main session was on trade unionism and putting the radical before the librarianship.

 

A week prior to the event, I put in a pitch myself:-

Maybe something about ‘Big Deals’ and how to get out of them ? There has an increasing movement against them of late.

Just a suggestion for a discussion.

I was pleasantly surprised that this was actually selected and a 30 minute discussion took place. This was kicked off (as informally agreed on the day) by a voluntary member of the group, Prof Charles Oppenheim, myself followed by a general discussion.

Some of the topics that may have come up (in no order):-

Recent cancellations of “Big Deals” in Europe and beyond.

FOI requests

Cost of journal subscriptions by Scottish Universities

Lawson S and Meghreblian B. Journal subscription expenditure of UK higher education institutions [version 3; referees: 4 approved]. F1000Research 2015, 3:274
(doi: 10.12688/f1000research.5706.3)

Sci-Hub

I think I am allowed to say that I made the closing remark, but I am not permitted to say what it was (Chatham House) but I may have pointed to some of the words on a t-shirt…

librarians

After a short lunch period, a workshop/cryptoparty session on internet security was had.

The event concluded at ~15:50 and as we had to vacate the building by 16:00, off we went having left our area in the same way in which we arrived.

Almost all of us then walked round to Bridgeton station and trained it back to Glasgow Central.

A somewhat brisk (was pishin’ it down at times) walk up Renfield Street to The Flying Duck for dinner/drinks etc.

flying-duck-optimised

I buggered off early but I understand there was some karaoke !!!!!!

Extracts of The Library of Alexandra

June 7, 2017

Carl1

On June 6th 2017, in a series of tweets, Carl Malamud @carlmalamud  unearthed a very interesting entity. Carl describes himself on Twitter as:-

Archivist. Usually Civil Servant. Founder of . Open Source America’s Operating System. It’s not just a good idea, it’s the law.

 

Carl Malamud is the President and Founder of Public.Resource.Org. The author of 8 books, Malamud was previously founder of the Internet Multicasting Service, a nonprofit that started the first radio station on the Internet and was responsible for making the SEC EDGAR database available. He is the recipient of the Berkman Award from Harvard, the Pioneer Award from the EFF, and the Bill Farr Award from the First Amendment Coalition.

SOURCE

And he concludes his thread with:-

In a subsequent tweet, he confirms that he will be taking this further:-

Carl1

I have since updated the Reception section of the Wikipedia page about Sci-Hub to reflect this.

 

Preprints – who to follow…

May 15, 2017

COS logo

I’ve touched upon the Center for Open Science previously on this blog. Looking back and ahead – Centre for Open Science

preprints

The following tweet from Brian Nosek @BrianNosek Executive Director at Center for Open Science @OSFramework was the conduit to this post.

A few tweets later

And thus, Preprint Explorers was created in real time. https://twitter.com/OSFramework/lists/preprint-explorers (now deleted) Another copy may follow 😉 (And indeed it did)

During this period, I thought about creating a list on here, and in no order (irrelevant)…

Conflict of Interest Statements (COIS) will now appear on PubMed Abstracts for all papers where indicated in publication.

April 20, 2017

pubmed image

New York University nutrition researcher Marion Nestle has been tracking industry-funded studies on her blog: 156 of 168 reported results that favored the funders’ interests. Annette Elizabeth Allen

This post was prompted by the following tweet:-

The link in the above tweet takes you to

Too many studies have hidden conflicts of interest. A new tool makes it easier to see them.

PubMed, the Google of scientific search, is now publishing funding information in its abstracts.

Great post by Julia Belluz @juliaoftoronto

My immediate response on Twitter

The screenshot in Julia’s post comes from….. PubMed PubMed Updates March 2017

Of the four changes mentioned, this is the most significant.

pm_update_fig1

The one example given by PubMed is from an Open Access (OA) paper indexed in PubMed Central (PMC) (additional arrow added).

PubMed COI

“PubMed will include conflict of interest statements below the abstract when these statements are supplied by the publisher”

Emphasis mine.

Generally speaking in terms of published research papers, COIs are largely hidden towards the end (if at all). They are vitally important IMO but this is the first time I’ve seen one indexed upfront in PubMed. Going back to a key point in Julia’s post:-

We strongly urge … all journals listed in PubMed to provide information about funding sources and other possible competing interests in all abstracts. To facilitate research, the “competing interest” section should be fully searchable. Thus, PubMed would advise users about the entity or entities that funded the study and whether (a) the authors reported no competing interests; (b) the authors reported the competing interests; (c) the article did not include a competing-interests disclosure statement; or (d) the journal did not provide disclosure of funding sources or the authors’ other competing interests.

pubmed pharma

SOURCE

In short my question is, will traditional/legacy/subscription based publishers make such important information freely available or remain hidden behind their paywalls ?

+++UPDATE 1+++

I asked my long term trusted contact at NCBI/NIH if they could confirm if these will appear widely or just on OA papers like the one mentioned.

They advised “I believe it’s on papers where indicated in publication”

+++UPDATE 2+++

I did a check on 22nd April to see if this change had been fully implemented. The following randomly picked papers were checked to see if COIs were mentioned in the Abstracts on PubMed. No mention made. Having read through the full texts of these, COIs appear in all of them. Clearly, still work to do for the PubMed team.

https://www.ncbi.nlm.nih.gov/pubmed/27249641
https://www.ncbi.nlm.nih.gov/pubmed/26631378
https://www.ncbi.nlm.nih.gov/pubmed/25246643

Extraordinary Everyday Lives #053 Open Science

April 16, 2017

ORIGINAL SOURCE c/o WAYBACK MACHINE

Update: A shorter and hopefully clearer version salvaged from Mikes analog backup recording has been posted and feds should now be getting this clearer file.

Update: Apologies for audio quality, some interference gremlins snuck in somewhere. We are looking at fixing it up somewhat and will republish the audio as soon as that’s done.

The Extraordinary Everyday Lives Show #053 Open Science
Thurs 24th July 2008

>>>>>>>>>>>> MP3 <<<<<<<<<<<<<<<<<<

This show is all about the intersection of Technology and Human desire. This year Dave and I have been focusing on deepening connections with those we subscribe to via RSS. Having a chat on a podcast is a remarkable way of doing that we have found. Agenda is loose guide only, we are very stream of consciousness, no edits, no script kinda guys.


New intro music this show. Courtesy of Graham, one of our guests. I remixed it a bit for the intro and play the full song, Wake Up Now, after the discussions.

Open Science

Rough chronological talking points:
-mike had nothing more than a vague idea such a movement would exist prior to starting work at a University in April.
-his RSS reader provided some clues to a trail which I followed Graham Steel was one of the first to respond to my thinking out loud
-how graham and mike hooked up
-richard discovered it after posting an experiment on his labrats blog, and people got in touch.
-two sides open scientific publication & open notebook scientists
-trust and sharing of unpublished latest work
-tension between competition and openness
-openness outwards facing and inclusionary of wider community sharing of scientific data
-paradigm shift involvement with and giving something back to community
-blogging science
-use of podcasts big uptake in unis
-richard is attending a Science Blogging event at the Royal Institute in London on Saturday 30th August
www.nature.com/natureconferences/sciblog2008/index.html. One of the science communications team at USyd interviewed me (richard) this morning about this conference. Very interesting: theyre really keen on the idea here. Im also going to an Open Science meet at Southampton two days after the London meeting, organized by Cameron Neylon.
-guys will try to record and live blog the london event
-whats this about? http://blog.openwetware.org/scienceintheopen/2008/07/21/the-full-web20-experience-my-talk-tomorrow-at-iwmw-in-aberdeen/
www.viddler.com/explore/CameronNeylon/videos/1/
-discussion about how to capture the esence of a event with blogging, podcasts etc. immediacy.
http://www.youtube.com/results?search_query=%22open+science%22&search_type=&aq=f
-going to use one of grahams songs for intro to this show http://www.macjams.com/song/34800 Wake Up Now
http://www.music20book.com/ Gerds book
-posters in 2nd Life http://www.flickr.com/photos/mikeblogs/195285627/
-mike talks about science in the sl community. specific uses of 3d environment.what are they good for in science? rf. mike crawling thru a molecule. [dnw]
-Knol somewhere between closed and open science use? http://knol.google.com/k/knol# (A knol is an authoritative article about a specific topic.)

Graham Steel http://twitter.com/McDawg

Networking between us public, science bloggers, scientists, researchers, physicians, Journals etc.

Nature Network http://network.nature.com/profile/steelgraham
Public Library of Science (PLoS) blog http://www.plos.org/cms/blog
Open Access Directory wiki http://oad.simmons.edu/
MacJams Music Blog http://blog.macjams.com/?p=223
Personal blog http://mcblawg.blogspot.com
Do Bloggers Add a New Dimension to Conferences? http://scienceblogs.com/clock/2008/01/science_blogging_conference_vi.php


Richard Grant (twitter: rpg_twit skype: rpg7sky AIM/iChat: rpg7aim)

Nature Network http://network.nature.com/blogs/user/rpg
University of Sydney http://blogs.usyd.edu.au/labrats/ Richards open science stuff
Personal blog http://rg-d.com/BioLOG/


LINKS and Random Stuff


The Royal Institution


http://www.science.usyd.edu.au/outreach/

http://www.oar2008.qut.edu.au/ Open access & research meeting in Brisbane towards the end of September. Some impressive names.
On the subject of technology and human desire, check out this presentation from Prof David Wishart in Canada. http://www.scribd.com/word/full/2159511?access_key=key-29c44pnl25896imfykd1 I mashed it a wee bit.

This just in:
http://dx.doi.org/10.1016/j.tree.2008.05.004
Over the past few years, blogging (‘web logging’) has become a major social movement, and as such includes blogs by scientists about science. Blogs are highly idiosyncratic, personal and ephemeral means of public expression, and yet they contribute to the current practice and reputation of science as much as, if not more than, any popular scientific work or visual presentation. It is important, therefore, to understand this phenomenon.

Acknowledgements

Intro music, Wake Up Now, by steck, via macjams.com.

Image: Culture Tubes, www.flickr.com/photos/10775233@N00/107326169

3 Responses to Extraordinary Everyday Lives #053 Open Science

  1. OpenScience on latest Extraordinary podcast | Learning with the Fang Says:
    […] has already posted yesterdays chat about OpenScience for our Extraordinary Everyday Lives podcast. It was a beaut chat with Graham and […]
  2. The Podcast Network Blog » Blog Archive » TPN Week In Review: July 28 – August 4 , 2008 Says:
    […] Extraordinary Everyday Lives #053 Open Science […]
  3. Speaking of Science | Learning with the Fang Says:
    […] discussion (thanks to Graham and Richard) on my last Extraordinary everyday lives podcast (episode 53), there seems to be some interest in connecting the event in London with people in other geography […]